Skip to main content
SpringerLink
Log in

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Although metastasis is a frequent event in breast cancer patients, insight into the clinical course, prognosis and therapy with respect to the site of the first metastases has been poor and contradictory in former investigations. Follow-up data from 648 patients with metastatic breast cancer were statistically analyzed. Patients with bone metastases at first relapse had better overall survival (median 71 vs. 48 months; p<0.001) and survival after first metastases (median 24 vs 12 months; p<0.001) than patients with visceral metastases at first relapse. Bone was the site of first metastasis in 46%, and 71% of patients with metastatic breast cancer developed bone metastases. The localization of the second metastatic site was of prognostic relevance in patients with first visceral metastases, but not in patients with first bone metastases. The presence of osseous metastases correlated significantly with estrogen and progesterone receptor positivity, tumor grading I/II and S-phase fraction <5%. The better prognosis of patients with bone metastases is not determined exclusively by hormone receptor status. The disease is significantly more stable in patients with first bone metastases than in those with first visceral metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Galasko CSB, Doyle FH: The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. Clin Radiol 23: 295–297, 1972

    Google Scholar 

  2. Roy RR, Nathan BE, Beales JSM, Chishoim GD: 18Fluorine total-body scans in patients with carcinoma of the prostate. Br J Urol 43: 58–64, 1971

    Google Scholar 

  3. Drury AB, Palmer PH, Highman WJ: Carcinomatous metastases to the vertebral bodies. J Clin Pathol 17: 448–4547, 1964

    Google Scholar 

  4. Tofe AJ, Francis MID, Harvey WJ: Correlation of neoplasms with incidence and localization of skeletal metastases. An analysis of 1355 diphosphonate bone scans. J Nucl Med 16: 986–989, 1975

    Google Scholar 

  5. Johnston AD: Pathology of metastatic tumors in bone. Clin Orthop 73: 8–32, 1970

    Google Scholar 

  6. Galasko CSB: Skeletal metastases. Butterworths, London, Boston, Sydney, pp. 14–21, 1986

    Google Scholar 

  7. Nielsen OS, Munro AJ, Tannock IF: Bone metastases: Pathology and management policy. J Clin Oncol 9: 509–524, 1991

    Google Scholar 

  8. Yamashita K, Takafumi U, Komatsubara Y, Koyama H, Inaji H, Yomenobu K, Ono K: Breast cancer with bone only metastases. Visceral metastases-free rate in relation to anatomic distribution of bone metastases. Cancer 69: 634–637, 1991

    Google Scholar 

  9. Body JJ, Coleman RE, Picart M: Use of bisphosphonates in cancer patients. Cancer Treat Rev 22: 265–287, 1996

    Google Scholar 

  10. Collett D: Modelling survival data in medical research. Chapman and Hall: London, 1994

    Google Scholar 

  11. Swenerton KD, Legha SS, Smith TL, Hortobagyi GN, Gehan EA, Yap HY, Gutterman JU, Blumenschein GR: Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39: 1552–1560, 1979

    Google Scholar 

  12. Kamby C, Vejborg I, Daugaard S: Clinical and radiological characteristics of bone metastases in breast cancer. Cancer 60: 2524–2531, 1987

    Google Scholar 

  13. Patanaphan V, Salazar OM, Poussin-Rosillo H: Prognosticators in recurrent breast cancer. A 15-year experience with irradiation. Cancer 54: 228–234, 1984

    Google Scholar 

  14. Scheid V, Buzdar AU, Smith TL, Hortobagyi GN: Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer 58: 2589–2593, 1986

    Google Scholar 

  15. Sherry MM, Greco FA, Johnson DA, Hainsworth JD: Metastatic breast cancer confined to the skeletal system: an indolent disease. Am J Med 81: 381–386, 1986

    Google Scholar 

  16. Smalley RV, Scogna DM, Malmud LS: Advanced breast cancer with bone-only metastases: a chemotherapeutically responsive pattern of metastases. Am J Clin Oncol 5: 161–166, 1982

    Google Scholar 

  17. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61–66, 1987

    Google Scholar 

  18. Coleman RE, Smith P, Rubens RD: Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77: 336–340, 1998

    Google Scholar 

  19. Kamby C: The pattern of metastases in human breast cancer: Methodological aspects and influence of prognostic factors. Cancer Treat Rev 17: 37–61, 1990

    Google Scholar 

  20. Perez JE, Machiavelli M, Leone BA, Romero A, Rabinowich MG, Vallejo CT, Bianco A, Rodriquez R, Cuevas MA, Alvarez LA: Bone-only versus visceral only metastatic pattern in breast cancer: analysis of 150 patients. Am J Clin Oncol 13: 294–298, 1990

    Google Scholar 

  21. Blanco G, Holli K, Heikkinen M, Kallioniemi O-P, Taskinen P: Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 62: 142–146, 1990

    Google Scholar 

  22. Fey MF, Brunner KW, Sonntag RW. Prognostic factors in metastatic breast cancer. Cancer Clin Trials 4: 237–247, 1981

    Google Scholar 

  23. Hietanen P, Miettinen M, Mäkinen J: Survival after first recurrence in breast cancer. Eur J Cancer Clin Oncol 22: 913–919, 1986

    Google Scholar 

  24. Clark GM, Sledge GW, Osborne CK, McGuire WL: Survival from first recurrence: relative importance of prognostic factors in 1, 015 breast cancer patients. J Clin Oncol 5: 55–61, 1987

    Google Scholar 

  25. Stewart TV, King RJ, Sext SA, Millis RR, Rubens RD, Hayward JL: Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer 17: 449–461, 1981

    Google Scholar 

  26. Kamby C, Andersen J, Ejlertsen B, Birkler NE, Rytter L, Zedeler K, Thorpe SM, Norgaard T, Rose C: Histological grade and steroid receptor content of primary breast cancer: Impact on prognosis and possible modes of action. Br J Cancer 58: 480–486, 1988

    Google Scholar 

  27. Solomayer E-F, Diel IT, Wallwiener D, Bastert G: Breast cancer with skeletal metastases at initial diagnosis. Analysis to prognosis, course and therapy. Geburtsh Frauenheilk 57: 629–636, 1997

    Google Scholar 

  28. Bundred NJ, Walker RA, Ratcliffe WA, Warwick J, Morrison JM, Ratcliffe JG: Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 28: 690–692, 1992

    Google Scholar 

  29. Diel IJ, Solomayer E-F, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan Ch, Pescherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 5: 3914–3919, 1999

    Google Scholar 

  30. Coleman RE: Evaluation of bone disease in breast cancer. The Breast 3: 73–78, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Heidelberg, USA

    E.-F. Solomayer, I.J. Diel, G.C. Meyberg, Ch. Gollan & G. Bastert

Authors
  1. E.-F. Solomayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I.J. Diel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G.C. Meyberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ch. Gollan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Bastert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solomayer, EF., Diel, I., Meyberg, G. et al. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59, 271–278 (2000). https://doi.org/10.1023/A:1006308619659

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006308619659

Search

Navigation